Eastwood M A, Allgood G S
Gastro-Intestinal Laboratory, Western General Hospital, Edinburgh, UK.
Eur J Clin Nutr. 1995 Sep;49(9):627-39.
To assess the effect of olestra consumption on breath hydrogen (H2) and methane (CH4) production and faecal microbial counts in humans consuming moderate or high fibre diets. A secondary objective was to assess the effect of olestra consumption on health status.
Thirty-six-day parallel, placebo-controlled, double-blind study with baseline low fibre period (3 g/meal, 8 days) and treatment period (28 days). Four treatment groups: moderate (7 g/meal) or high fibre (24 g/meal), with olestra (24 g) or placebo.
Queen Margaret College, Edinburgh, Scotland.
Ninety-seven adult subjects (30 males and 67 females) from the hospital staff and student population participated in the study. Ninety-four subjects successfully completed the study.
Breath H2 and CH4 production were measured and faecal specimens were obtained for faecal microbial viable counts and direct microscopic cell counts at the end of the baseline period and the end of the treatment period. Standard clinical blood and urine assays were performed. Subjects were questioned regarding adverse events.
Olestra demonstrated no significant effect on breath H2 or CH4 production following either moderate or high fibre intake. A trend for lower breath H2 production in the high fibre olestra group was seen. No effect of olestra consumption on faecal microbial counts or health status was observed.
In normal subjects 24 g/d of olestra for 36 days does not interfere with normal intestinal fermentation of dietary fibre and does not significantly alter gut microflora populations.
评估食用奥利司他对食用中等或高纤维饮食的人群呼出氢气(H2)和甲烷(CH4)产生以及粪便微生物计数的影响。次要目的是评估食用奥利司他对健康状况的影响。
为期36天的平行、安慰剂对照、双盲研究,包括基线低纤维期(每餐3克,共8天)和治疗期(28天)。四个治疗组:中等纤维(每餐7克)或高纤维(每餐24克),分别添加奥利司他(24克)或安慰剂。
苏格兰爱丁堡玛格丽特女王学院。
97名来自医院工作人员和学生群体的成年受试者(30名男性和67名女性)参与了研究。94名受试者成功完成了研究。
在基线期结束和治疗期结束时,测量呼出的H2和CH4产生量,并采集粪便样本进行粪便微生物活菌计数和直接显微镜细胞计数。进行标准的临床血液和尿液检测。询问受试者有关不良事件的情况。
在摄入中等或高纤维后,奥利司他对呼出的H2或CH4产生量均无显著影响。高纤维奥利司他组呼出的H2产生量有降低趋势。未观察到食用奥利司他对粪便微生物计数或健康状况有影响。
在正常受试者中,连续36天每天摄入24克奥利司他不会干扰膳食纤维的正常肠道发酵,也不会显著改变肠道微生物群落。